| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
7,352 |
6,344 |
$1.92M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,414 |
10,296 |
$1.36M |
| X4011 |
State-specific procedure code |
3,539 |
3,239 |
$1.28M |
| A0425 |
Ground mileage, per statute mile |
11,422 |
9,353 |
$616K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
2,378 |
2,006 |
$577K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
6,595 |
3,439 |
$524K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
18,047 |
16,503 |
$398K |
| 80053 |
Comprehensive metabolic panel |
17,155 |
15,667 |
$396K |
| X4006 |
|
791 |
494 |
$276K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
997 |
893 |
$216K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,769 |
1,579 |
$173K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,270 |
2,790 |
$133K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,237 |
2,912 |
$110K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
565 |
498 |
$91K |
| 97597 |
|
2,162 |
1,416 |
$89K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
938 |
852 |
$58K |
| Y7506 |
|
531 |
492 |
$41K |
| X4003 |
|
743 |
558 |
$41K |
| 71046 |
Radiologic examination, chest; 2 views |
765 |
710 |
$35K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
741 |
682 |
$29K |
| 36415 |
Collection of venous blood by venipuncture |
5,834 |
5,159 |
$26K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
346 |
308 |
$20K |
| 81001 |
|
4,261 |
3,831 |
$19K |
| Y7507 |
|
143 |
133 |
$18K |
| 84443 |
Thyroid stimulating hormone (TSH) |
892 |
865 |
$14K |
| 84484 |
|
1,140 |
1,007 |
$12K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
148 |
129 |
$8K |
| 80061 |
Lipid panel |
752 |
712 |
$8K |
| 62323 |
|
140 |
135 |
$8K |
| 43253 |
|
17 |
12 |
$8K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
408 |
400 |
$7K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
249 |
219 |
$7K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
965 |
850 |
$6K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
103 |
94 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
68 |
59 |
$5K |
| 83655 |
|
663 |
642 |
$4K |
| 83690 |
|
35 |
29 |
$4K |
| 84439 |
|
75 |
75 |
$4K |
| 87070 |
|
761 |
745 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
84 |
76 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
47 |
37 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
45 |
43 |
$2K |
| 62321 |
|
30 |
30 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
197 |
189 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
348 |
267 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
551 |
517 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
14 |
14 |
$1K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
16 |
14 |
$949.92 |
| 87040 |
|
38 |
36 |
$601.21 |
| 85014 |
|
519 |
509 |
$532.42 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
14 |
12 |
$485.00 |
| 86850 |
|
66 |
65 |
$472.17 |
| 86900 |
|
161 |
149 |
$459.73 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
14 |
14 |
$414.41 |
| 83880 |
|
26 |
24 |
$368.10 |
| 84703 |
|
90 |
78 |
$362.49 |
| 83605 |
|
44 |
38 |
$319.20 |
| 86901 |
|
159 |
147 |
$255.12 |
| 85610 |
|
86 |
74 |
$146.59 |
| 36416 |
|
62 |
60 |
$137.55 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
29 |
24 |
$122.48 |
| 81025 |
|
25 |
24 |
$34.40 |
| 85730 |
|
14 |
12 |
$29.65 |
| 81003 |
|
13 |
13 |
$9.00 |
| J3490 |
Unclassified drugs |
1,093 |
666 |
$0.00 |
| 11045 |
|
22 |
12 |
$0.00 |
| 87430 |
|
13 |
12 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
55 |
27 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
21 |
14 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
112 |
56 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13 |
12 |
$0.00 |
| T1015 |
Clinic visit/encounter, all-inclusive |
58 |
38 |
$0.00 |